Omnicare shows second quarter profit

Share this article:

Omnicare Inc. turned a profit in the second quarter, according to a statement from the nursing home pharmacy giant. Omnicare earned $18.7 million, or 17 cents per share, for the three months ended June 30. That compares with a loss of $1.5 million, or 1 cent per share, a year earlier. Interim Chief Executive John Workman, the company's president and chief financial officer, said the latest results reflect positive trends its generic-drugs segment and continued growth at its specialty-care business.

Share this article:
close

Next Article in Products

More in Products

Nurse technology contest seeks applications

Nurses who want to share the ways technology has led to a better student or patient outcome are invited to enter a contest that touts two $10,000 cash awards.

Accessory for swimming approved for cochlear implants

Accessory for swimming approved for cochlear implants ...

The Food and Drug Administration has approved the Aqua+ accessory, a waterproof, behind-the-ear product for cochlear implant recipients. The accessory allows Cochlear™ Nucleus® 5 and Nucleus 6 Implant recipients2 to ...

Non-Invasive Open Ventilation System approved

Non-Invasive Open Ventilation System approved

Breathe Technologies, which makes the Non-Invasive Open Ventilation (NIOV) System, said the Food and Drug Administration has granted the fifth 510(k) clearance for the product.